Neuphoria Therapeutics Inc. (NEUP)

NASDAQ

$3.34

$--

(0.00%)

Pre-Market

Neuphoria Therapeutics Inc. (NEUP) Live Price Chart

Last updated: ⁦2026-10-13 12:10:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Neuphoria Therapeutics Inc. (NEUP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.34, with a market capitalisation of $18.18M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.19 to $18.39. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$18.18M
Open	$3.34
Day's High	$21.40
Day's Low	$2.90
Previous Close	$3.32
Volume	5.00
Average Volume	163.01K
P/E Ratio	--
52-Week High	$18.39
52-Week Low	$3.19
Dividend Yield	--
Earnings Date	--

Neuphoria Therapeutics Inc. (NEUP) Pre-Market Stock Price

Neuphoria Therapeutics Inc. (NEUP) is trading at $3.34 in pre-market trading as of 2026-10-13 11:44:00, up 0.60% ($0.02) from the previous close of $3.32

Pre-market trading shows how investors are pricing NEUP before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Neuphoria Therapeutics Inc. (NEUP) 7-Day Stock Price Change

Over the past seven days, Neuphoria Therapeutics Inc. (NEUP) moved from $3.47 to $3.34, representing a decline of 3.75% ($0.13).

The stock traded between $3.32 and $3.59 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 11.15 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

NEUP 52-Week Price Position

Position in Range: 1.0%

52W Low$3.19

52W High$18.39

NEUP is currently trading at $3.34, placing it 1.0% of the way from its 52-week low of $3.19 to its 52-week high of $18.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Neuphoria Therapeutics Inc. (NEUP)?

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.

Neuphoria Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1
Exchange	NASDAQ
Company Website	https://www.neuphoriatx.com

How to Buy Neuphoria Therapeutics Inc. (NEUP) Stock on MEXC

Eligible investors can buy real shares of Neuphoria Therapeutics Inc. (NEUP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NEUP and Place Your Order

Open the RealStocks trading page and search for NEUP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Neuphoria Therapeutics Inc. (NEUP) stock price today?

Neuphoria Therapeutics Inc. (NEUP) is currently trading at $ 3.34, up 0.60% ($0.02) from the previous close of $ 3.32. Intraday prices update in real time during regular trading hours.

2.Is NEUP stock going up or down today?

As of 2026-10-13 11:44:00, NEUP is trading at $ 3.34, up 0.60% ($0.02) from its previous close of $ 3.32. The stock has traded between $ 2.90 and $ 21.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is NEUP pre-market price?

As of 2026-10-13 11:44:00, NEUP is trading at $ 3.34 in pre-market trading, up 0.60% ($0.02) from the previous close of $ 3.32. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NEUP after-hours price?

As of 2026-10-13 11:44:00, NEUP is trading at $ 3.34 in after-hours trading, up 0.60% ($0.02) from the regular-session close of $ 3.32. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NEUP stock trading now?

NEUP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NEUP sit relative to its 52-week high and low?

Over the past 52 weeks, NEUP has traded between a low of $ 3.19 and a high of $ 18.39. At $ 3.34, the stock is positioned 1.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Neuphoria Therapeutics Inc. in?

Neuphoria Therapeutics Inc. (NEUP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Neuphoria Therapeutics Inc.'s market capitalisation and where is it listed?

Neuphoria Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 18.18M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NEUP valued in terms of P/E ratio and EPS?

NEUP trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Neuphoria Therapeutics Inc. pay a dividend?

Neuphoria Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.